A citation-based method for searching scientific literature

Alejandro Mendoza-Alvarez, Beatriz Guillen-Guio, Adrian Baez-Ortega, Carolina Hernandez-Perez, Sita Lakhwani-Lakhwani, Maria-Del-Carmen Maeso, Jose M Lorenzo-Salazar, Manuel Morales, Carlos Flores. Front Genet 2019
Times Cited: 5







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.
Lucy Gossage, Muhammed Murtaza, Andrew F Slatter, Conrad P Lichtenstein, Anne Warren, Beverley Haynes, Francesco Marass, Ian Roberts, Susan J Shanahan, Andreas Claas,[...]. Genes Chromosomes Cancer 2014
93
40

Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.
James J Hsieh, David Chen, Patricia I Wang, Mahtab Marker, Almedina Redzematovic, Ying-Bei Chen, S Duygu Selcuklu, Nils Weinhold, Nancy Bouvier, Kety H Huberman,[...]. Eur Urol 2017
105
40

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
A Ari Hakimi, Ying-Bei Chen, James Wren, Mithat Gonen, Omar Abdel-Wahab, Adriana Heguy, Han Liu, Shugaku Takeda, Satish K Tickoo, Victor E Reuter,[...]. Eur Urol 2013
145
40

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.
Murim Choi, Ute I Scholl, Weizhen Ji, Tiewen Liu, Irina R Tikhonova, Paul Zumbo, Ahmet Nayir, Ayşin Bakkaloğlu, Seza Ozen, Sami Sanjad,[...]. Proc Natl Acad Sci U S A 2009
833
40

Performance comparison of exome DNA sequencing technologies.
Michael J Clark, Rui Chen, Hugo Y K Lam, Konrad J Karczewski, Rong Chen, Ghia Euskirchen, Atul J Butte, Michael Snyder. Nat Biotechnol 2011
316
40

New insights into the performance of human whole-exome capture platforms.
Janine Meienberg, Katja Zerjavic, Irene Keller, Michal Okoniewski, Andrea Patrignani, Katja Ludin, Zhenyu Xu, Beat Steinmann, Thierry Carrel, Benno Röthlisberger,[...]. Nucleic Acids Res 2015
65
40

Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.
James J Hsieh, Brandon J Manley, Nabeela Khan, JianJiong Gao, Maria I Carlo, Emily H Cheng. Semin Cell Dev Biol 2017
32
20

Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
Shan-Shan Wang, Yi-Feng Gu, Nicholas Wolff, Karoliina Stefanius, Alana Christie, Anwesha Dey, Robert E Hammer, Xian-Jin Xie, Dinesh Rakheja, Ivan Pedrosa,[...]. Proc Natl Acad Sci U S A 2014
86
20

Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy.
Isabel Heidegger, Andreas Pircher, Renate Pichler. Front Oncol 2019
26
20

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Samra Turajlic, Hang Xu, Kevin Litchfield, Andrew Rowan, Tim Chambers, Jose I Lopez, David Nicol, Tim O'Brien, James Larkin, Stuart Horswell,[...]. Cell 2018
269
20

Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies.
Alessia Cimadamore, Francesco Massari, Matteo Santoni, Veronica Mollica, Vincenzo Di Nunno, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi, Holger Moch. Expert Rev Mol Diagn 2020
6
20

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
Qingquan Zeng, Shuolei Sun, Yaxian Li, Xiaoling Li, Zuwei Li, Hao Liang. Front Oncol 2020
22
20

Evolution of Renal Cell Carcinoma.
Zayd Tippu, Lewis Au, Samra Turajlic. Eur Urol Focus 2021
6
20


Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5.
Sandy Giuliano, Maeva Dufies, Papa Diogop Ndiaye, Julien Viotti, Delphine Borchiellini, Julien Parola, Valérie Vial, Yann Cormerais, Mickaël Ohanna, Véronique Imbert,[...]. Theranostics 2019
10
20

Detergent-Free Simultaneous Sample Preparation Method for Proteomics and Metabolomics.
Alexandre Zougman, John P Wilson, Lee D Roberts, Rosamonde E Banks. J Proteome Res 2020
4
25


Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis.
Roberto Iacovelli, Franco Nolè, Elena Verri, Giuseppe Renne, Chiara Paglino, Matteo Santoni, Maria Cossu Rocca, Palma Giglione, Gaetano Aurilio, Daniela Cullurà,[...]. Target Oncol 2016
91
20

Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
Cristina Grange, Alessia Brossa, Benedetta Bussolati. Int J Mol Sci 2019
15
20

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.
Nicole Kiweler, Boris Brill, Matthias Wirth, Ines Breuksch, Teresa Laguna, Cornelia Dietrich, Susanne Strand, Günter Schneider, Bernd Groner, Falk Butter,[...]. Arch Toxicol 2018
31
20

Renal cell carcinoma.
James J Hsieh, Mark P Purdue, Sabina Signoretti, Charles Swanton, Laurence Albiges, Manuela Schmidinger, Daniel Y Heng, James Larkin, Vincenzo Ficarra. Nat Rev Dis Primers 2017
654
20

Golgi Phosphoprotein 3 Promotes Malignant Phenotypes via FAK/Raf/MEK and Wnt/β-Catenin Signaling Pathways in Human Renal Cell Carcinoma.
Meifang He, Zongren Wang, Wei Hu, Kebing Wang, Dong Wang, Zeng Fang, Anpei Huang, Ying Gao, Jintang Xia, Wen Li. J Biomed Nanotechnol 2019
5
20

Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.
Enyang Zhao, Lihong Li, Wenfu Zhang, Wanhui Wang, Yunhui Chan, Bosen You, Xuedong Li. J Transl Med 2019
8
20

Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.
Piotr Popławski, Takayuki Tohge, Joanna Bogusławska, Beata Rybicka, Zbigniew Tański, Victor Treviño, Alisdair R Fernie, Agnieszka Piekiełko-Witkowska. Biochim Biophys Acta Mol Basis Dis 2017
13
20

Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Ashley Di Meo, Ihor Batruch, Marshall D Brown, Chuance Yang, Antonio Finelli, Michael A Jewett, Eleftherios P Diamandis, George M Yousef. Int J Cancer 2020
7
20

Implication of VHL, ERK5, and HIF-1alpha in clear cell renal cell carcinoma: Molecular basis.
Leticia Serrano-Oviedo, José M Giménez-Bachs, Syongh Y Nam-Cha, Francisco J Cimas, Jesús García-Cano, Ricardo Sánchez-Prieto, Antonio S Salinas-Sánchez. Urol Oncol 2017
7
20


Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
20

Sunitinib activates Axl signaling in renal cell cancer.
Johannes C van der Mijn, Henk J Broxterman, Jaco C Knol, Sander R Piersma, Richard R De Haas, Henk Dekker, Thang V Pham, Victor W Van Beusechem, Balazs Halmos, James W Mier,[...]. Int J Cancer 2016
23
20


Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
Ninadh M D'Costa, Matthew R Lowerison, Peter A Raven, Zheng Tan, Morgan E Roberts, Raunak Shrestha, Matthew W Urban, Cesar U Monjaras-Avila, Htoo Zarni Oo, Antonio Hurtado-Coll,[...]. J Exp Clin Cancer Res 2020
8
20

Update on proteomic studies of formalin-fixed paraffin-embedded tissues.
Laura Giusti, Cristina Angeloni, Antonio Lucacchini. Expert Rev Proteomics 2019
11
20

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
David J Clark, Saravana M Dhanasekaran, Francesca Petralia, Jianbo Pan, Xiaoyu Song, Yingwei Hu, Felipe da Veiga Leprevost, Boris Reva, Tung-Shing M Lih, Hui-Yin Chang,[...]. Cell 2020
16
20

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Mahul B Amin, Frederick L Greene, Stephen B Edge, Carolyn C Compton, Jeffrey E Gershenwald, Robert K Brookland, Laura Meyer, Donna M Gress, David R Byrd, David P Winchester. CA Cancer J Clin 2017
20

Connecting Histopathology Imaging and Proteomics in Kidney Cancer through Machine Learning.
Francisco Azuaje, Sang-Yoon Kim, Daniel Perez Hernandez, Gunnar Dittmar. J Clin Med 2019
6
20

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
Wei Zhang, Wenjie Xia, Zhengye Lv, Chao Ni, Yin Xin, Liu Yang. Cell Physiol Biochem 2017
111
20

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy.
Alessia Cimadamore, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi. Cancers (Basel) 2019
14
20

Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.
Patrick Schuhmacher, Emily Kim, Felix Hahn, Peggy Sekula, Cordula Annette Jilg, Christian Leiber, Hartmut P Neumann, Wolfgang Schultze-Seemann, Gerd Walz, Stefan Zschiedrich. Orphanet J Rare Dis 2019
6
20

The proteomic landscape of renal tumors.
Clizia Chinello, Vincenzo L'imperio, Martina Stella, Andrew James Smith, Giorgio Bovo, Angelica Grasso, Marco Grasso, Francesca Raimondo, Marina Pitto, Fabio Pagni,[...]. Expert Rev Proteomics 2016
8
20

The silent disease.
Graham Shaw. Nature 2016
4
25

Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Clizia Chinello, Martina Stella, Isabella Piga, Andrew James Smith, Giorgio Bovo, Marta Varallo, Mariia Ivanova, Vanna Denti, Marco Grasso, Angelica Grasso,[...]. J Proteomics 2019
13
20


Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy.
Yongchang Lai, Tao Zeng, Xiongfa Liang, Weizou Wu, Fangling Zhong, Wenqi Wu. Cancer Cell Int 2019
6
20

Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.
Lea Landolt, Øystein Eikrem, Philipp Strauss, Andreas Scherer, David H Lovett, Christian Beisland, Kenneth Finne, Tarig Osman, Mohammad M Ibrahim, Gro Gausdal,[...]. Physiol Rep 2017
15
20

Cancer diagnosis: from tumor to liquid biopsy and beyond.
Ramanathan Vaidyanathan, Ren Hao Soon, Pan Zhang, Kuan Jiang, Chwee Teck Lim. Lab Chip 2018
53
20

Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer.
Yimeng Song, Lijun Zhong, Juntuo Zhou, Min Lu, Tianying Xing, Lulin Ma, Jing Shen. Proteomics Clin Appl 2017
19
20

Group Lasso Regularized Deep Learning for Cancer Prognosis from Multi-Omics and Clinical Features.
Gangcai Xie, Chengliang Dong, Yinfei Kong, Jiang F Zhong, Mingyao Li, Kai Wang. Genes (Basel) 2019
15
20

Preoperative imaging in renal cell cancer.
Axel Heidenreich, Vincent Ravery. World J Urol 2004
73
20


Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes.
Nicole Kiweler, Désirée Wünsch, Matthias Wirth, Nisintha Mahendrarajah, Günter Schneider, Roland H Stauber, Walburgis Brenner, Falk Butter, Oliver H Krämer. J Cancer Res Clin Oncol 2020
9
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.